Patent intelligence · US
US 10786435
Composition for optical three-dimensional modeling
Composition for optical three-dimensional modeling
Patent details — US 10786435
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 29, 2020
- Expiration
- Sep 24, 2040
- Applicant
- KURARAY NORITAKE DENTAL INC.
- Claims
- 12
- CPC classes
- A61K, A61K6/60, A61K6/62, A61K6/71
Quick answer
US 10786435 (Composition for optical three-dimensional modeling) is held by KURARAY NORITAKE DENTAL INC.. Status: granted. Granted Sep 29, 2020. Expires Sep 24, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- KURARAY NORITAKE DENTAL INC.
- Grant date
- Expiration
- Claims
- 12
- CPC classes
- A61K, A61K6/60, A61K6/62, A61K6/71, A61K6/80, A61K6/84
More from KURARAY NORITAKE DENTAL INC.
Related pharmaceutical patents in our USPTO index.
-
US 12410184
Crystalline forms of a menin inhibitor
granted -
US 12377026
Dental adhesive material kit
granted -
US 12358210
Resin composition for stereolithography
granted -
US 12344691
Resin composition for stereolithography
granted -
US 12214061
Adhesive composition for dental use
granted -
US 12208148
Dental restorative curable composition
granted -
US 12145888
Zirconia molded body and pre-sintered body capable of being sintered in short time
granted -
US 12138325
Dental composition
granted
Frequently asked questions
What is US patent 10786435?
US 10786435 (Composition for optical three-dimensional modeling) is held by KURARAY NORITAKE DENTAL INC.. Status: granted. Granted Sep 29, 2020. Expires Sep 24, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10786435?
KURARAY NORITAKE DENTAL INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 132 pharmaceutical patents for this assignee.
When does US 10786435 expire?
Our index shows an expiration date of Sep 24, 2040 (14 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.